Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Permeability Enhancement to Reduce Chronic Inflammation _ Medium Cut Off (MCO) (Study no 1502)

NCT02084381 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT02084381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Permeability Enhancement to Reduce Chronic Inflammation _ Medium Cut Off (MCO) (Study no 1502)
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
February 28, 2015
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammation, chronic kidney failure